Revolutionary Step in B2B: The First Verified & Trusted Pharma, Surgical & Medical Trade Automation Platform • Direct Factory Deals, Global Tenders & 7-Document Export Dossiers•Revolutionary Step in B2B: The First Verified & Trusted Pharma, Surgical & Medical Trade Automation Platform • Direct Factory Deals, Global Tenders & 7-Document Export Dossiers•
WHO Guidelines & GMP Standards

WHO Technical Report Series Update: Water for Injection (WFI) Membrane Generation & TOC Control

Updated Good Manufacturing Practice (GMP) technical guidance addressing non-distillation Water for Injection (WFI) production via dual-pass Reverse Osmosis (RO) coupled with Electrodeionization (EDI) and ultrafiltration. Harmonized with Ph. Eur. Monograph 0169 and USP <1231> water system specifications.

  • Critical Limits: Total Organic Carbon (TOC) ≤ 500 ppb; bacterial endotoxins < 0.25 EU/mL; total viable aerobic count ≤ 10 CFU/100 mL; temperature-compensated conductivity ≤ 1.1 μS/cm at 20°C.
  • Validation Mandate: Manufacturers must maintain continuous online TOC/conductivity monitoring and 12-month seasonal biofilm trend evaluations.

Official Source & Verification Reference

Issuing Authority: World Health Organization (WHO) • Reference: WHO-TRS-1044-WFI-2026

Verify Official Source Document ↗
WHO Technical Report Series Update: Water for Injection (WFI) Membrane Generation & TOC Control | PharmaTrade Online Market Bulletin | PharmaTrade Online